Theranos Scrutiny Shows FDA's Murky Oversight Of Lab Tests
The U.S. Food and Drug Administration dealt health-testing startup Theranos Inc. a setback with an inspection report designating its signature thumbtack-size blood sample vial an "uncleared medical device," in a case...To view the full article, register now.
Already a subscriber? Click here to view full article